NovoCure Limited (NVCR) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NVCR Revenue Growth
Revenue Breakdown
NVCR's revenue distribution by segment and geography
By Geography
NVCR Revenue Analysis (2014–2025)
As of May 8, 2026, NovoCure Limited (NVCR) generated trailing twelve-month (TTM) revenue of $674.4 million, reflecting strong growth of +12.3% year-over-year. The most recent quarter (Q1 2026) recorded $174.1 million in revenue, down 0.2% sequentially.
Looking at the longer-term picture, NVCR's 5-year compound annual growth rate (CAGR) stands at +5.8%, indicating steady revenue expansion. The company achieved its highest annual revenue of $655.4 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), INVA (+13.6% YoY), and SUPN (+16.3% YoY), NVCR has underperformed the peer group in terms of revenue growth. Compare NVCR vs NKTR →
NVCR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NVCRCurrent | $674M | +12.3% | +5.8% | -23.5% | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% | |
 SUPN | $719M | +16.3% | +6.7% | -5.1% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 IDXX | $4.3B | +13.1% | +9.7% | 31.6% |
NVCR Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $655.4M | +8.3% | $488.5M | 74.5% | $-153,800,000 | -23.5% |
| 2024 | $605.2M | +18.8% | $468.0M | 77.3% | $-170,496,000 | -28.2% |
| 2023 | $509.3M | -5.3% | $381.1M | 74.8% | $-232,870,000 | -45.7% |
| 2022 | $537.8M | +0.5% | $423.0M | 78.6% | $-89,523,000 | -16.6% |
| 2021 | $535.0M | +8.2% | $420.2M | 78.5% | $-44,333,000 | -8.3% |
| 2020 | $494.4M | +40.7% | $387.9M | 78.5% | $30.4M | 6.1% |
| 2019 | $351.3M | +41.6% | $262.7M | 74.8% | $-914,000 | -0.3% |
| 2018 | $248.1M | +40.1% | $168.0M | 67.7% | $-33,672,000 | -13.6% |
| 2017 | $177.0M | +113.6% | $121.4M | 68.6% | $-39,328,000 | -22.2% |
| 2016 | $82.9M | +150.5% | $36.6M | 44.2% | $-115,317,000 | -139.1% |
See NVCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVCR — Frequently Asked Questions
Quick answers to the most common questions about buying NVCR stock.
Is NVCR's revenue growth accelerating or slowing?
NVCR maintains +12.3% revenue growth, in line with its 5-year CAGR of +5.8%. TTM revenue stands at $674M. Growth rate remains consistent with historical average.
What is NVCR's long-term revenue growth rate?
NovoCure Limited's 5-year revenue CAGR of +5.8% reflects the sustained expansion pattern. Current YoY growth of +12.3% is near this long-term average.
How is NVCR's revenue distributed by segment?
NVCR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.